BCL2L1 and head and neck squamous cell carcinoma: Hypertonicity-induced functional loss of MCL-1 renders BCL-XL a synthetically lethal target in head and neck squamous cell carcinoma (HNSCC), and inhibiting BCL-XL efficiently kills HNSCC cells that respond poorly to conventional therapies [42].